These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27614009)

  • 1. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
    Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
    Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
    Laizure SC; Parker RB; Herring VL; Hu ZY
    Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formation.
    Laizure SC; Chen F; Farrar JE; Ali D; Yang B; Parker RB
    Drug Metab Pharmacokinet; 2022 Dec; 47():100479. PubMed ID: 36375226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.
    Shi J; Wang X; Eyler RF; Liang Y; Liu L; Mueller BA; Zhu HJ
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):555-561. PubMed ID: 27228223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.
    Shi J; Wang X; Nguyen J; Wu AH; Bleske BE; Zhu HJ
    Drug Metab Dispos; 2016 Apr; 44(4):554-9. PubMed ID: 26817948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of dabigatran etexilate interindividual variability.
    Dimatteo C; D'Andrea G; Vecchione G; Paoletti O; Cappucci F; Tiscia GL; Buono M; Grandone E; Testa S; Margaglione M
    Thromb Res; 2016 Aug; 144():1-5. PubMed ID: 27261537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Distribution of the Genotypes of
    Abdrakhmanov A; Akilzhanova A; Shaimerdinova A; Zhalbinova M; Tuyakova G; Abildinova S; Albayev R; Ainabekova B; Chinybayeva A; Suleimen Z; Bekbossynova M
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
    Sychev D; Skripka A; Ryzhikova K; Bochkov P; Shevchenko R; Krupenin P; Ivashchenko D; Kogay V; Listratov A; Krainyaya A; Gurinovich O; Sokolova A; Napalkov D; Fomin V
    Drug Metab Pers Ther; 2020 Mar; 35(1):. PubMed ID: 32134727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers.
    Wang X; Her L; Xiao J; Shi J; Wu AH; Bleske BE; Zhu HJ
    Clin Transl Sci; 2021 Jul; 14(4):1380-1389. PubMed ID: 33660934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
    Wang X; Wang G; Shi J; Aa J; Comas R; Liang Y; Zhu HJ
    Pharmacogenomics J; 2016 Jun; 16(3):220-30. PubMed ID: 26076923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
    Merali Z; Ross S; Paré G
    Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism.
    Hu ZY; Parker RB; Herring VL; Laizure SC
    Anal Bioanal Chem; 2013 Feb; 405(5):1695-704. PubMed ID: 23239178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of dabigatran plasma levels and their relation to bleeding.
    Paré G; Eriksson N; Lehr T; Connolly S; Eikelboom J; Ezekowitz MD; Axelsson T; Haertter S; Oldgren J; Reilly P; Siegbahn A; Syvanen AC; Wadelius C; Wadelius M; Zimdahl-Gelling H; Yusuf S; Wallentin L
    Circulation; 2013 Apr; 127(13):1404-12. PubMed ID: 23467860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of ABCB1 and CES1 Polymorphisms on Plasma Levels of Dabigatran and Risk of Hemorrhagic Complications in Ischemic Stroke Patients.
    Olšerová A; Janský P; Magerová H; Šrámková T; Kešnerová P; Kmetonyová S; Šulc V; Halmová H; Šrámek M; Šarbochová I; Paulasová-Schwabová J; Benešová K; Macek J; Maťoška V; Tomek A
    Am J Ther; 2024 Jul-Aug 01; 31(4):e362-e371. PubMed ID: 38525959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.
    Zhu HJ; Wang X; Gawronski BE; Brinda BJ; Angiolillo DJ; Markowitz JS
    J Pharmacol Exp Ther; 2013 Mar; 344(3):665-72. PubMed ID: 23275066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
    Her L; Zhu HJ
    Drug Metab Dispos; 2020 Mar; 48(3):230-244. PubMed ID: 31871135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Cathepsin A and Carboxylesterase 1 to the Hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis.
    Li J; Shi J; Xiao J; Tran L; Wang X; Zhu HJ
    Drug Metab Dispos; 2022 Mar; 50(3):243-248. PubMed ID: 34933885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically-Based Pharmacokinetic Modeling to Predict Methylphenidate Exposure Affected by Interplay Among Carboxylesterase 1 Pharmacogenetics, Drug-Drug Interactions, and Sex.
    Xiao J; Shi J; Thompson BR; Smith DE; Zhang T; Zhu HJ
    J Pharm Sci; 2022 Sep; 111(9):2606-2613. PubMed ID: 35526575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects.
    Her LH; Wang X; Shi J; Choi HJ; Jung SM; Smith LS; Wu AH; Bleske BE; Zhu HJ
    Br J Clin Pharmacol; 2021 Dec; 87(12):4691-4700. PubMed ID: 33963573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin.
    Qian Y; Gilliland TK; Markowitz JS
    Chem Biol Interact; 2020 Jan; 316():108914. PubMed ID: 31837295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.